Jefferies sees Amgen (AMGN) 'moving back up'

April 4, 2023 7:54 AM EDT Send to a Friend
Jefferies analyst Michael Yee reiterated a Buy rating and $325.00 price target on Amgen (NASDAQ: AMGN)."AMGN has a 2nd req ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login